CRISPR–Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung Cancer
Jesse Boumelha(The Francis Crick Institute), Julian Downward(The Francis Crick Institute)
Cited by 32
Related Papers
Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences
|Nature|1984|2.5k
Therapeutic KRAS <sup>G12C</sup> inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers
|Science Advances|2022|134
Regulation of Akt(ser473) phosphorylation by Choline kinase in breast carcinoma cells
|Molecular Cancer|2009|72
CUTL1 Is Phosphorylated by Protein Kinase A, Modulating Its Effects on Cell Proliferation and Motility
|Journal of Biological Chemistry|2006|28
Viral pro-survival proteins block separate stages in Bax activation but changes in mitochondrial ultrastructure still occur
|Cell Death and Differentiation|2008|23